Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Kadcyla
Pharma
Daiichi Sankyo dials up Enhertu projection
Daiichi Sankyo now expects Enhertu could reach JPY 195.2 billion ($1.31 billion) sales in FY2022, a big increase from the previous JPY 128.4 billion.
Angus Liu
Oct 31, 2022 12:17pm
AZ, Daiichi's Enhertu, after 2 recent nods, notches trial win
Aug 15, 2022 11:45am
AZ, Daiichi's Enhertu leaps into 2L breast cancer
May 5, 2022 7:55am
Seagen undaunted by AstraZeneca-Daiichi's Enhertu
Oct 29, 2021 3:32pm
AZ-Daiichi, Biogen-Samsung, Clover and more—Fierce Pharma Asia
Sep 24, 2021 8:45am
Enhertu delivers massive progression edge over Kadcyla
Sep 18, 2021 9:05am
